It was also found that in samples of colorectal cancer metastases, the levels of the cytoplasmic and nuclear expression of CD133 were reduced in both cancer cells and cells of the tumor microenvironment compared with samples from primary lesions. This evidence concerns the gene PROM1 and colorectal cancer.